Background image

AbbVie’s Botox Notches Mid-Stage Win in Essential Tremor

Posted on October 8, 2025

AbbVie’s Botox (onabotulinumtoxinA) hit the main goal in a mid-stage study of upper limb essential tremor, potentially setting up another indication for the therapeutic neurotoxin. The company announced the top-line findings ahead of presentation at the ongoing International Congress of Parkinson’s Disease and Movement Disorders.